FM-AFT regression analysis indicated a two-component model, with genes such as CDH11, EPB41L3, and DOCK2 associated with more aggressive forms of CRC, while TMEM215, PPP1R14A, GPR158, and NAPSB were linked to less aggressive forms. The gene discussed is EPB41L3; the disease is colorectal carcinoma.